We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

 AstraZeneca enters generic drugs market

i-law is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
i-law.com
i-law.com

Patent World Magazine

AstraZeneca enters generic drugs market

INDIA – AstraZeneca has signed up to a partnership with Indian generic drug maker Torrent Pharmaceuticals, as it seeks to boost its presence in emerging markets and counter patent losses on blockbuster medicines.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer
Login

Not yet an i-law subscriber?

Devices

Request a trial Find out more